128 related articles for article (PubMed ID: 3456250)
1. C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies.
Romero P; Blick M; Talpaz M; Murphy E; Hester J; Gutterman J
Blood; 1986 Mar; 67(3):839-41. PubMed ID: 3456250
[TBL] [Abstract][Full Text] [Related]
2. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
Gale RP; Canaani E
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5648-52. PubMed ID: 6091099
[TBL] [Abstract][Full Text] [Related]
3. Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization.
Bartram CR; de Klein A; Hagemeijer A; Grosveld G; Heisterkamp N; Groffen J
Blood; 1984 Jan; 63(1):223-5. PubMed ID: 6336312
[TBL] [Abstract][Full Text] [Related]
4. Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.
Kozbor D; Giallongo A; Sierzega ME; Konopka JB; Witte ON; Showe LC; Croce CM
Nature; 1986 Jan 23-29; 319(6051):331-3. PubMed ID: 3455750
[TBL] [Abstract][Full Text] [Related]
5. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
Collins SJ
J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
[TBL] [Abstract][Full Text] [Related]
6. Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22).
Gradl G; Tesch H; Schwieder G; Wagner T; Fonatsch C
Blut; 1989 Jun; 58(6):279-85. PubMed ID: 2660925
[TBL] [Abstract][Full Text] [Related]
7. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
Rosson D; Reddy EP
Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
[TBL] [Abstract][Full Text] [Related]
8. Philadelphia-positive chronic myelogenous leukemia with breakpoint 5' of the breakpoint cluster region but within the bcr gene.
Bartram CR; Bross-Bach U; Schmidt H; Waller HD
Blut; 1987 Dec; 55(6):505-11. PubMed ID: 3480009
[TBL] [Abstract][Full Text] [Related]
9. Additional c-abl/bcr rearrangements in a CML patient exhibiting two ph1 chromosomes during blast crisis.
Bartram CR; de Klein A; Hagemeijer A; Carbonell F; Kleihauer E; Grosveld G
Leuk Res; 1986; 10(2):221-5. PubMed ID: 3005778
[TBL] [Abstract][Full Text] [Related]
10. The c-abl, bcr and C lambda genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leukemia.
Blick MB; Andersson BS; Gutterman JU; Keating A; Beran M
Leuk Res; 1986; 10(12):1401-9. PubMed ID: 3099097
[TBL] [Abstract][Full Text] [Related]
11. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
[TBL] [Abstract][Full Text] [Related]
12. Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis.
Westbrook CA; Rubin CM; Carrino JJ; Le Beau MM; Bernards A; Rowley JD
Blood; 1988 Mar; 71(3):697-702. PubMed ID: 3422829
[TBL] [Abstract][Full Text] [Related]
13. Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis.
Collins SJ; Groudine MT
Blood; 1987 Mar; 69(3):893-8. PubMed ID: 3545323
[TBL] [Abstract][Full Text] [Related]
14. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
15. "Masked" Ph1-chromosome in chronic myelogenous leukaemia (CML).
Verma RS; Dosik H
Blut; 1985 Mar; 50(3):129-33. PubMed ID: 3856457
[TBL] [Abstract][Full Text] [Related]
16. Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells.
Collins SJ; Kubonishi I; Miyoshi I; Groudine MT
Science; 1984 Jul; 225(4657):72-4. PubMed ID: 6587568
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations.
Abe S; Minamihisamatsu M; Ishihara T; Sasaki M
Cancer Genet Cytogenet; 1989 Mar; 38(1):61-74. PubMed ID: 2713815
[TBL] [Abstract][Full Text] [Related]
18. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).
Clark SS; McLaughlin J; Timmons M; Pendergast AM; Ben-Neriah Y; Dow LW; Crist W; Rovera G; Smith SD; Witte ON
Science; 1988 Feb; 239(4841 Pt 1):775-7. PubMed ID: 3422516
[TBL] [Abstract][Full Text] [Related]
19. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562.
Collins SJ; Groudine MT
Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4813-7. PubMed ID: 6308652
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
